Patents
Patents for C07K 19 - Hybrid peptides (29,428)
06/2011
06/07/2011US7956038 GASP1: a follistatin domain containing protein
06/07/2011US7955600 Attenuated salmonella SP12 mutants as antigen carriers
06/07/2011US7955590 Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
06/07/2011CA2438787C Virus derived antimicrobial peptides
06/07/2011CA2378866C Fc fusion proteins for enhancing the immunogenicity of protein and peptide antigens
06/07/2011CA2230556C Novel procollagens
06/07/2011CA2187083C Peptide fragment of the respiratory syncytial virus g protein, immunogenic agent, pharmaceutical composition containing same, and preparation method
06/03/2011WO2011066285A2 Peptide-based treatment for neurodegenerative diseases
06/03/2011WO2011065935A1 Methods for monoclonal antibody production
06/03/2011WO2011064736A1 Optimized endonucleases and uses thereof
06/03/2011WO2011063921A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors
06/03/2011WO2011025158A3 Coacervate having an ionic polymer mixed with the adhesive protein of a mussel or of a species of the variome thereof
06/03/2011WO2011020045A9 Combined use of gdf traps and erythropoietin receptor activators to increase red blood cell levels
06/03/2011CA2782014A1 Optimized endonucleases and uses thereof
06/03/2011CA2779353A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (timp) linked to glycosylphosphatidylinositol (gpi)-anchors
06/02/2011US20110130550 Protein monomer, protein polymer obtained from said monomer, and device that contains them
06/02/2011US20110130541 Inhibitors of Bacterial Tyrosine Kinase and Uses Thereof
06/02/2011US20110129477 NOGO Receptor Homologs
06/02/2011US20110129457 Variant hhip1 protein and methods and uses thereof
06/01/2011EP2327775A2 Therapy for alpha-galactosidase a deficiency
06/01/2011EP2327719A1 Hybrid and tandem expression of neisserial proteins
06/01/2011EP2326333A1 Agent for promoting neuronal differentiation and method therefor
06/01/2011DE102009047243A1 Monospezifische Polypeptidreagenzien Monospecific Polypeptidreagenzien
06/01/2011CN102080098A Eukaryon expression vector and application thereof to preparing medicament for inhibiting leukemia cell proliferation
06/01/2011CN102079790A Recombination fusion protein PACAP-PTD (Pituitary Adenylate Cyclase Activating Peptide-Protein Transduction Domain) as well as expression method and application thereof
06/01/2011CN101362795B Epitope of epididymal protease inhibitor B cell and antigen peptides containing thereof
06/01/2011CN101343328B Target-specificity dual-mutant amalgamation protein
05/2011
05/31/2011US7951919 TACI-immunoglobulin fusion proteins
05/31/2011US7951546 Compositions and methods for the diagnosis and treatment of tumor
05/31/2011US7951378 Modified cell adhesion molecule comprising immunoglobulin heavy chain fusion for treatment and prevention of respiratory system disorders
05/31/2011US7951371 Soluble lymphotoxin-β receptor fusion protein and methods for inhibiting lymphotoxin β-receptor signaling
05/31/2011CA2339324C Protein delivery system using human papillomavirus virus-like particles
05/26/2011WO2011063277A1 Anti-orai1 antigen binding proteins and uses thereof
05/26/2011WO2011063235A2 Peptides, devices, and methods for the detection of ehrlichia antibodies
05/26/2011WO2011063160A1 Methods for improving oral delivery
05/26/2011WO2011063003A2 Peptides and methods for the detection of lyme disease antibodies
05/26/2011WO2011061937A1 Methods for producing antibody-producing cells that produce desired polypeptides
05/26/2011WO2011060583A1 Nonnatural collagen-like protein and use thereof
05/26/2011US20110124564 Nucleolin-binding peptides, nucleolin- binding lytic peptides, fusion constructs and methods of making and using same
05/26/2011US20110124081 Nuclear factor of activated t cells receptor
05/26/2011US20110123509 Fusion molecules of rationally-designed dna-binding proteins and effector domains
05/26/2011CA2818241A1 Methods for improving oral delivery
05/26/2011CA2781532A1 Anti-orai1 antigen binding protein that binds the second extracellular loop of orai1
05/26/2011CA2781117A1 Peptides, devices, and methods for the detection of ehrlichia antibodies
05/26/2011CA2781110A1 Peptides and methods for the detection of lyme disease antibodies
05/26/2011CA2780678A1 Compositions for increasing polypeptide stability and activity, and related methods
05/26/2011CA2780242A1 Multivalent antibodies
05/25/2011EP2325317A1 Receptor nucleic acids and polypeptides
05/25/2011EP2324847A1 Acceleration of wound healing by a tissue inhibitor of metalloproteinases (TIMP) linked to glycosylphosphatidylinositol (GPI)-anchors
05/25/2011EP2324844A2 April receptor (BCMA) and uses thereof
05/25/2011EP2324063A2 Non-invasive fetal rhd genotyping from maternal whole blood
05/25/2011EP2324062A1 Chimeric respiratory syncytial virus polypeptide antigens
05/25/2011EP2324058A1 Biological applications of steroid binding domains
05/25/2011EP1366077B1 PROCESS FOR HIGH THROUGHPUT SCREENING OF CpG-BASED IMMUNO-AGONIST/ANTAGONIST
05/25/2011EP1345959B1 Membrane scaffold proteins
05/25/2011CN102070719A Soluble leukemia stem cell targeting proteins TrxHis-hCD47
05/25/2011CN102070718A Polyclonal antibodies of human tau protein exons 2, 3 and 10
05/25/2011CN102070717A Fusion protein, preparation method thereof, DNA sequence for coding protein, expression vector, host cell and protein-containing medicinal compoisition
05/25/2011CN101519451B Recombinant human cytotoxic T lymphocyte associate antigen-4 fusion protein gene (sCTLA4-Ig) and pharmaceutical composition thereof
05/25/2011CN101519450B Fusion protein and use of fusion protein in detection of histoplasma capsulatum
05/24/2011US7947810 Kits for diagnosing a hypophosphatemic disorder
05/24/2011US7947281 Chimeric proteins that induce effects directed against viruses
05/24/2011US7947277 Wnt antagonists and their use in the diagnosis and treatment of Wnt-mediated disorders
05/24/2011CA2440596C Soluble heterodimeric cytokine receptor
05/24/2011CA2385266C Novel cell cycle checkpoint genes and proteins encoded thereby
05/24/2011CA2337754C Recombinant multivalent malarial vaccine against plasmodium falciparum
05/24/2011CA2323072C Gfr.alpha.3 and its uses
05/24/2011CA2319310C Equine fc epsilon receptor alpha chain nucleic acid molecules, corresponding proteins and uses thereof
05/24/2011CA1341615C Targeted multifunctional proteins
05/24/2011CA1341614C Targeted multifuncional proteins
05/19/2011WO2011060260A2 Compositions and methods for prevention of escape mutation in the treatment of her2/neu over-expressing tumors
05/19/2011WO2010144602A3 Antigen-norovirus p-domain monomers and dimers, antigen-norovirus p-particle molecules, and methods for their making and use
05/19/2011US20110118439 Three-Dimensional Structure Of The Amyloid Precursor Protein Intracellular Domain (AICD) In Complex With Human FE65-PTB2
05/19/2011US20110118136 Capture compounds, collections thereof and methods for analyzing the proteome and complex compositions
05/19/2011US20110117556 High-sensitive fluorescent energy transfer assay using fluorescent amino acids and fluoresent proteins
05/19/2011US20110117168 Methods and compositions for soft tissue repair
05/19/2011US20110117167 Methods and compositions for soft tissue repair
05/19/2011US20110117117 Novel immunogenic epitopes for immunotherapy
05/19/2011US20110117113 Immunoglobulin single variable domain directed against human cxcr4 and other cell associated proteins and methods to generate them
05/19/2011US20110117093 Antibodies that immunospecifically bind to b lymphocyte stimulator protein
05/19/2011US20110117082 Soluble Tumor Necrosis Factor Receptor Mutant
05/19/2011CA2780542A1 Von willebrand factor (vwf)-containing preparations, and methods, kits, and uses related thereto
05/19/2011CA2778809A1 Antibody glycosylation variants
05/18/2011EP2322933A1 Diagnosis of carcinomas
05/18/2011EP2322929A1 Diagnostics, drug screening and treatment for cancer
05/18/2011EP2322614A1 Recombinational cloning using engineered recombination sites
05/18/2011EP2322609A1 Hcv/gbv-b chimeric virus
05/18/2011EP2322228A1 T cell receptor fusions and conjugates and methods of use thereof
05/18/2011CN102066422A Lysosomal targeting peptides and uses thereof
05/18/2011CN102066421A Bifunctional fusion proteins of the alpha-melanocyte stimulating hormone (alpha-MSK) and atrial natriuretic protein (ANP) and uses in hypertension and acute kidney injury
05/18/2011CN102061303A Fusion expression product of antimicrobial peptide genes of two marine animals and preparation method of fusion expression product
05/18/2011CN102060930A HHscFv-Rcr gene sequence and method for preparing transgenic tobacco
05/18/2011CN102060929A T-cell immune balance peptide
05/18/2011CN102060928A Bombesin-oriented anti-tumor polypeptide and preparation method and application thereof
05/18/2011CN102060924A Single domain antibody aiming at deoxynivalenol (DON)
05/18/2011CN102060913A Heptapeptide combined with human serum albumin and application thereof
05/18/2011CN101481422B Antineoplastic target fusion protein with release switch and use thereof
05/18/2011CN101362794B B cell epitope of follicle-stimulating hormone receptor and antigen peptides containing thereof
05/18/2011CN101225114B Method for breeding pest-resistant plants as well as special proteins and genes therefor
05/17/2011US7943574 Cell-permeable peptide inhibitors of the JNK signal transduction pathway
1 ... 45 46 47 48 49 50 51 52 53 54 55 56 57 58 59 60 61 62 63 64 65 ... 295